Generated: December 11, 2017
DrugPatentWatch Database Preview
Thioridazine hydrochloride - Generic Drug Details
« Back to Dashboard
What are the generic sources for thioridazine hydrochloride and what is the scope of thioridazine hydrochloride freedom to operate?
is the generic ingredient in three branded drugs marketed by Novartis, Actavis Mid Atlantic, Alpharma Us Pharms, Ani Pharms Inc, Hi Tech Pharma, Pharm Assoc, Sandoz, Wockhardt, Roxane, Mutual Pharm, Mylan, Par Pharm, Sun Pharm Industries, Superpharm, Watson Labs, Watson Labs Teva, and West Ward, and is included in eighty NDAs. Additional information is available in the individual branded drug profile pages.
There are eighteen drug master file entries for thioridazine hydrochloride. Four suppliers are listed for this compound.
Summary for thioridazine hydrochloride
Pharmacology for thioridazine hydrochloride
|Novartis||MELLARIL||thioridazine hydrochloride||TABLET;ORAL||011808-011||Approved Prior to Jan 1, 1982||DISCN||Yes||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs||THIORIDAZINE HYDROCHLORIDE||thioridazine hydrochloride||TABLET;ORAL||088869-001||Jun 28, 1985||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Mylan||THIORIDAZINE HYDROCHLORIDE||thioridazine hydrochloride||TABLET;ORAL||088004-002||Mar 15, 1983||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Superpharm||THIORIDAZINE HYDROCHLORIDE||thioridazine hydrochloride||TABLET;ORAL||089104-001||Jul 2, 1985||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Ani Pharms Inc||THIORIDAZINE HYDROCHLORIDE||thioridazine hydrochloride||TABLET;ORAL||088456-001||May 17, 1985||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs||THIORIDAZINE HYDROCHLORIDE||thioridazine hydrochloride||TABLET;ORAL||088563-001||May 11, 1984||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Par Pharm||THIORIDAZINE HYDROCHLORIDE||thioridazine hydrochloride||TABLET;ORAL||089765-001||Feb 9, 1988||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs||THIORIDAZINE HYDROCHLORIDE||thioridazine hydrochloride||TABLET;ORAL||088345-001||Jul 28, 1983||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Novartis||MELLARIL||thioridazine hydrochloride||TABLET;ORAL||011808-003||Approved Prior to Jan 1, 1982||DISCN||Yes||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs||THIORIDAZINE HYDROCHLORIDE||thioridazine hydrochloride||TABLET;ORAL||088755-001||Jul 24, 1984||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.